CYLD and Obesity: In this study, we observed that IKK promoted renal injury caused by obesity through CYLD phosphorylation and that an IKK inhibitor could alleviate lipid deposition and oxidative stress injury in ORN, which may provide a feasible target for the treatment of kidney damage caused by ORN.